News
CNMD
70.01
-1.82%
-1.30
CONMED Corporation Promotes Patrick Beyer To Chief Operating Officer, Effective Immediately
Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer. He will take on additional responsibility for leading the Company's commercial businesses. Mr. Beyer joined CONMED in 2014 as president of international and global orthopedics.
Benzinga · 18h ago
Conmed Names Patrick Beyer to New COO Role
Conmed names Patrick Beyer to the newly created role of chief operating officer. Beyer is president of international and global orthopedics at Conmed. He will lead the company's commercial business, operations and distribution, among other things. The medical technology company named Beyer in 2014.
Dow Jones · 18h ago
Conmed Announces Executive Leadership Changes and Compensation Updates
TipRanks · 18h ago
Oversold Conditions For CONMED (CNMD)
NASDAQ · 18h ago
CONMED promotes Patrick Beyer to chief operating officer
CONMED promotes Patrick Beyer to chief operating officer. Mr. Beyer joined CONMED in 2014 as President of International. He will be promoted to the newly created role of Chief Operating Officer, effective immediately. CONMED Corporation (CNMD) stock.
Seeking Alpha · 19h ago
*Conmed Names Patrick Beyer to Newly Created Role of COO >CNMD
Dow Jones · 19h ago
*CONMED Corporation Promotes Patrick Beyer To Chief Operating Officer >CNMD
Dow Jones · 19h ago
*Conmed Cuts 2024 View To Rev $1.33B-$1.35B >CNMD
Dow Jones · 19h ago
BRIEF-Conmed Q1 Net Income USD 19.709 Million Vs. IBES Estimate USD 23.1 Million
BRIEF-Conmed Q1 Net Income USD 19.709 million vs. IBES estimate of USD 23.1 million. Conmed reports Q1 earnings per share of $0.63. The company says it expects FY revenue of $10 million and adjusted EPS of $4.35.
Reuters · 19h ago
CONMED CORP - FULL-YEAR REPORTED REVENUE IS NOW EXPECTED TO BE BETWEEN $1.330 BLN AND $1.355 BLN
Reuters · 19h ago
*Conmed 1Q Sales $312.3M >CNMD
Dow Jones · 19h ago
*Conmed 1Q EPS 63c >CNMD
Dow Jones · 19h ago
Press Release: CONMED Corporation Announces First Quarter 2024 Financial Results
CONMED Corporation announces financial results for the first quarter ended March 31, 2024. Sales of $312.3 million increased 5.7% year-over-year. Domestic revenue increased 7.2% and international revenue increased 3.8% in constant currency. Company now expects full-year 2024 revenue to be between $1.5 billion and $2 billion. Company will host a conference call today to discuss its first quarter 2024 results.
Dow Jones · 19h ago
Press Release: CONMED Corporation Announces First -2-
For the three months ended March 31, 2023, the company reported sales of $155,321. The company expects sales to rise to $250,000 in the second quarter of 2023. Sales are expected to grow to $300,000 by the end of the year. Sales will be driven by the growth of the company's e-commerce.
Dow Jones · 19h ago
*Conmed: Expect Incremental Rev Currency Headwinds of Approximately $10M in 2024 >CNMD
Dow Jones · 19h ago
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer. He will take on additional responsibility for leading the Company’s commercial businesses. Mr. Beyer joined CONMED in 2014 as President of international and global orthopedics.
Barchart · 1d ago
Noteworthy Tuesday Option Activity: KNTK, PLTR, CNMD
NASDAQ · 1d ago
Weekly Report: what happened at CNMD last week (0415-0419)?
Weekly Report · 3d ago
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
CONMED Corporation (NYSE:CNMD) is currently trading at a price of US$72.76 on the NYSE. The mid-cap stock has seen a substantial price movement over the last few months. The company is expected to double in the next few years. Is CONMED currently undervalued, or is it a good stock to buy? We take a look at the company's outlook and value to find out.
Simply Wall St · 04/18 10:42
Weekly Report: what happened at CNMD last week (0408-0412)?
Weekly Report · 04/15 09:21
More
Webull provides a variety of real-time CNMD stock news. You can receive the latest news about Conmed Corp through multiple platforms. This information may help you make smarter investment decisions.
About CNMD
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.